Hypidone
Hypidone (developmental code name YL-0919) is an investigational serotonergic antidepressant which is under development for the treatment of major depressive disorder.
≈ 1 min read
Names in other languages
No names in other languages are held for this entry yet.
Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.
Hypidone (developmental code name YL-0919) is an investigational serotonergic antidepressant which is under development for the treatment of major depressive disorder. It acts as a serotonin reuptake inhibitor, 5-HT 1A receptor partial agonist, and 5-HT 6 receptor full agonist. It is used as the hydrochloride salt. As of January 2021, hypidone is in phase 2 clinical trials for major depressive disorder.
See also
List of investigational antidepressants
External links
Hypidone hydrochloride - AdisInsight
Text derived from https://en.wikipedia.org/w/index.php?oldid=1372021215 under CC BY-SA 4.0; modifications have been made.